Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
OMIM | RCV000585672 | SCV000693442 | risk factor | BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19 | 2018-03-28 | no assertion criteria provided | literature only | |
Prevention |
RCV004748831 | SCV005361138 | uncertain significance | ADCY3-related disorder | 2023-12-30 | no assertion criteria provided | clinical testing | The ADCY3 c.3357_3359delCTT variant is predicted to result in an in-frame deletion (p.Phe1119del). This variant, also known as c.3354_3356del, has been reported in the compound heterozygous state in a patient with severe obesity and was associated with decreased catalytic activity in functional assays (see family 4 in Saeed et al. 2018. PubMed ID: 29311637). This variant is reported in 0.0062% of alleles in individuals of African descent in gnomAD. We suspect this variant is a cause of disease when present with a pathogenic variant on the other chromosome. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |